Long term performance characteristics of an electrochemical nitric oxide analyser
Summary Background The NIOX MINO® is a nitric oxide (FENO ) analyser based on electrochemical technology. It includes a replaceable sensor. Quality control procedures are recommended, but regular calibration is not possible. We aimed to evaluate the performance characteristics of the NIOX MINO® to i...
Gespeichert in:
Veröffentlicht in: | Respiratory medicine 2011-02, Vol.105 (2), p.211-217 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Summary Background The NIOX MINO® is a nitric oxide (FENO ) analyser based on electrochemical technology. It includes a replaceable sensor. Quality control procedures are recommended, but regular calibration is not possible. We aimed to evaluate the performance characteristics of the NIOX MINO® to identify if reproducibility changed over time, or with different sensors. Also, there are reports that reproducibility of FENO may be reduced in patients with high FENO : our secondary aim was to address this issue. Methods Reproducibility in 24 separate sensor-analyser units was calculated on three occasions over two months in 17 patients. These included 9 patients whose FENO was high (mean 80 ppb) and 8 in whom FENO was low (mean 16 ppb). Results One device failed quality control testing. For the remaining 23 sensor-analyser combinations, the mean coefficient of variation was 4.0% (range 1.2–7.2%) at baseline, 3.6% (range 2.0–7.0) at one month, and 3.6% (range 1.6–7.6%) at two months. The 95% C.I. for the mean limits of agreement for FENO was ±4.2 ppb (range 0.9–9.6 ppb), ±3.8 ppb (range 1.6–6.9 ppb) and ±3.2 ppb (range 1.2–6.8 ppb) respectively (NS). The limits of agreement exceeded the manufacturer’s specifications (±5 ppb) in 0 devices at baseline, 3 (13%) at one month, and 5 (22%) at two months. Conclusions Reproducibility of FENO using the NIOX MINO® was within clinically acceptable limits (±10 ppb) and was generally stable. However, with time, a proportion of individual sensor-analyser combinations yielded variability outside the manufacturer’s specifications. |
---|---|
ISSN: | 0954-6111 1532-3064 |
DOI: | 10.1016/j.rmed.2010.09.001 |